ASCVac-1, a Multi-Peptide Chimeric Vaccine, Protects Mice Against Ascaris suum Infection
Control of human ascariasis, the most prevalent neglected tropical disease globally affecting 450 million people, mostly relies on mass drug administration of anthelmintics.However, chemotherapy alone is not efficient due to the high re-infection rate for people who live in the endemic area.The development of a vaccine that reduces the intensity of